Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy-Reference-Cited by-同舟云学术

Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy

Published:2021-03 Issue:3 Volume:205 Page:748-754
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Meng Xiaosong¹²,Chao Brian¹,Chen Fei³,Huang Richard¹,Taneja Samir S.¹⁴⁵,Deng Fang-Ming³

Affiliation:

1. Department of Urology, Division of Urologic Oncology, NYU Langone Health, New York, New York

2. Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas

3. Departments of Pathology, NYU Langone Health, New York, New York

4. Departments of Radiology, NYU Langone Health, New York, New York

5. Departments of Biomedical Engineering, NYU Langone Health, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limited Utility of Dynamic Contrast Enhancement Imaging Sequences Within the PI-RADS v2.1 Classification Scheme: A Retrospective Cross-Sectional Study of MRI Reports;Canadian Association of Radiologists Journal;2024-08-28

2. Intraoperative margin assessment with near real time pathology during partial gland ablation of prostate cancer: A feasibility study;Urologic Oncology: Seminars and Original Investigations;2024-08

3. Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10‐year single‐centre cohort;BJUI Compass;2024-07-10

4. Natural history of histologically benign PIRADS 4–5 lesions in multiparametric MRI: Real‐life experience in an academic center;The Prostate;2024-06-25

5. Follow-up on Patients with Initial Negative mpMRI Target and Systematic Biopsy for PI-RADS ≥3 Lesions – An EAU-YAU Study Enhancing Prostate Cancer Detection.;2024-05-07